FDA Inspection 1221694 — ALLECRA THERAPEUTICS SAS
The FDA completed an inspection of ALLECRA THERAPEUTICS SAS on October 24, 2023 in St Louis. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 24, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- St Louis (France)
Additional Details
Sponsor, Contract Research Organization